Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling. (Q55069337)
Jump to navigation
Jump to search
scientific article published in December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling. |
scientific article published in December 2014 |
Statements
Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling. (English)
1 reference
Michael J Keating
1 reference
Julie R McMullen
1 reference
Esther J H Boey
1 reference
Jenny Y Y Ooi
1 reference
John F Seymour
1 reference
Constantine S Tam
1 reference
1 December 2014
1 reference
1 reference
124
1 reference
25
1 reference
3829-3830
1 reference